Lipidomic Signatures Informs Intravenous Racemic Ketamine Associated Remission in Treatment-Resistant Depression: A Pilot Study

被引：0
|
作者：
Singh, Balwinder [1 ]
MahmoudianDehkordi, Siamak [1 ]
Voort, Jennifer Vande [1 ]
Han, Xianlin [1 ]
Port, John [1 ]
Frye, Mark [1 ]
Daouk, Rima Kaddurah [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2022年 / 47卷
关键词：
IV; Ketamine; Metabolomics Signature; Treatment; Resistant Depression; Open Label Trials;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P227
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [1] Lipidomic Signatures Informs Intravenous Racemic Ketamine Associated Remission in Treatment-Resistant Depression: A Pilot Study
    Singh, Balwinder
    MahmoudianDehkordi, Siamak
    Vande Voort, Jennifer
    Han, Xianlin
    Port, John
    Frye, Mark
    Daouk, Rima Kaddurah
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 192 - 192
  • [2] Lipidomic Signatures Inform Intravenous Racemic Ketamine Associated Remission in Treatment-Resistant Depression: A Feasibility Trial
    Singh, Balwinder
    MahmoudianDehkordi, Siamak
    Voort, Jennifer Vande
    Han, Xianlin
    Port, John
    Frye, Mark
    Kaddurah-Daouk, Rima
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S23 - S24
  • [3] Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study
    Singh, Balwinder
    MahmoudianDehkordi, Siamak
    Vande Voort, Jennifer L.
    Han, Xianlin
    Port, John D.
    Frye, Mark A.
    Kaddurah-Daouk, Rima
    PSYCHIATRY RESEARCH, 2022, 314
  • [4] Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
    Rivas-Grajales, Ana Maria
    Salas, Ramiro
    Robinson, Meghan E.
    Qi, Karen
    Murrough, James W.
    Mathew, Sanjay J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (05) : 383 - 391
  • [5] A randomized controlled pilot study of daily intravenous ketamine over three days for treatment-resistant depression
    Pattanaseri, Keerati
    Lortrakul, Juthawadee
    Jaisin, Kankamol
    Srifuengfung, Maytinee
    Sa-nguanpanich, Naratip
    Viravan, Natee
    Pariwatcharakul, Pornjira
    Makarasara, Wattanan
    Ratta-apha, Woraphat
    BMC PSYCHIATRY, 2024, 24 (01)
  • [6] Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series
    Tham, Joseph C. W.
    Do, Andre
    Fridfinnson, Jason
    Rafizadeh, Reza
    Siu, Jacky T. P.
    Budd, George P.
    Lam, Raymond W.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2022, 37 (05) : 206 - 214
  • [7] Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression
    Jesus-Nunes, Ana Paula
    Leal, Gustavo C.
    Correia-Melo, Fernanda S.
    Vieira, Flavia
    Mello, Rodrigo P.
    Caliman-Fontes, Ana Teresa
    Echegaray, Mariana V. F.
    Marback, Roberta F.
    Guerreiro-Costa, Livia N. F.
    Souza-Marques, Breno
    Santos-Lima, Cassio
    Souza, Lucca S.
    Bandeira, Igor D.
    Kapczinski, Flavio
    Lacerda, Acioly L. T.
    Quarantini, Lucas C.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022, 37 (04)
  • [8] Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study
    Wlodarczyk, Adam
    Cubala, Wieslaw J.
    Galuszko-Wegielnik, Maria
    Szarmach, Joanna
    MEDICINE, 2021, 100 (29) : E26769
  • [9] Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study
    Cullen, Kathryn R.
    Amatya, Palistha
    Roback, Mark G.
    Albott, Christina Sophia
    Schreiner, Melinda Westlund
    Ren, Yanan
    Eberly, Lynn E.
    Carstedt, Patricia
    Samikoglu, Ali
    Gunlicks-Stoessel, Meredith
    Reigstad, Kristina
    Horek, Nathan
    Tye, Susannah
    Lim, Kelvin O.
    Klimes-Dougan, Bonnie
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (07) : 437 - 444
  • [10] Intravenous ketamine therapy in a patient with a treatment-resistant major depression
    Liebrenz, Michael
    Borgeat, Alain
    Leisinger, Ria
    Stohler, Rudolf
    SWISS MEDICAL WEEKLY, 2007, 137 (15-16) : 234 - 236
12345